A pilot randomised controlled trial of metacognitive therapy for prolonged grief.

ABSTRACT:

Objectives

Prolonged grief disorder is associated with significant distress and impairment and thus efforts to improve treatments are essential. The present pilot study tested the efficacy and feasibility of group Metacognitive Grief Therapy (MCGT) designed specifically for prolonged grief symptomatology to reduce the psychological distress and impaired function resulting from bereavement.

Design/participants

Twenty-two bereaved adult participants with prolonged grief symptomatology were randomised to a wait-list control (n=10) or an intervention condition (n=12) with a 3-month and 6-month follow-up. The wait-list control group was offered treatment after the post-test assessment.

Intervention

Participants attended six group MCGT sessions that ran for 2 hours per week

SUBMITTER: Wenn JA 

PROVIDER: S-EPMC6340007 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature